Literature DB >> 12584506

Responsiveness of the Bournemouth and Oswestry questionnaires: a prospective pilot study.

Michael Perillo1, Ronald Bulbulian.   

Abstract

BACKGROUND: The assessment of health-related quality-of-life outcome information has become an essential feature in the delivery of quality health care. Outcome assessment and increased clinical research capacity have been identified as recommended areas of priority for chiropractic research, chiropractic colleges, and the profession.
OBJECTIVE: This article reports the results of a multisite pilot project utilizing New York Chiropractic College's 3 off-campus health centers. In the project, we sought to examine generic issues related to research infrastructure and feasibility, perform pilot testing of the responsiveness of the revised Oswestry Disability Index (ODI) and the Bournemouth Questionnaire (BQ), and develop estimates of change and population size for the possible future projects.
METHODS: We describe the infrastructure created to conduct the project, including an on-site clinician research manager; on-site student research assistants; identification, recruitment, and patient flow; demographic and clinical characteristics; and abstraction instruments. Responsiveness study subjects completed 3 health-related quality-of-life assessments at baseline, 15 days, and 30 days. At 45 days, or at discharge, subjects completed the same questionnaires and a global rating of change. Responsiveness is reported by analysis of standardized estimates of change, relative efficiency, and receiver operator characteristic (ROC) curve plots.
RESULTS: We successfully identified 82% of possible study patients; the real eligibility rate in our population was 30%. In 4 months, 70 patients were accrued, and 26 patients followed through to provide global ratings of change scores. Responsiveness by standardized change scores was numerical rating scale (NRS) = 1.19, ODI = 0.91, BQ = 0.78; by relative efficiency it was BQ/ODI = 0.86, ODI/NRS = 0.76, BQ/NRS = 0.66. Area under the curves ranged from 0.69 for the BQ to 0.86 for the NRS.
CONCLUSIONS: Recommendations for modification and use of the infrastructure, research capacity, and future outcome and appropriateness assessment projects are offered.

Entities:  

Mesh:

Year:  2003        PMID: 12584506     DOI: 10.1067/mmt.2003.6

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  6 in total

1.  A randomized clinical trial comparing non-thrust manipulation with segmental and distal dry needling on pain, disability, and rate of recovery for patients with non-specific low back pain.

Authors:  D Griswold; F Gargano; K E Learman
Journal:  J Man Manip Ther       Date:  2019-02-09

2.  Low Back Pain Response to Pelvic Tilt Position: An Observational Study of Chiropractic Patients.

Authors:  Salvatore J Minicozzi; Brent S Russell; Kathryn J Ray; Alessandria Y Struebing; Edward F Owens
Journal:  J Chiropr Med       Date:  2016-03-25

3.  Responsiveness of the Brazilian-Portuguese version of the Oswestry Disability Index in subjects with low back pain.

Authors:  Rodrigo A Coelho; Fabiano B Siqueira; Paulo H Ferreira; Manuela L Ferreira
Journal:  Eur Spine J       Date:  2008-05-30       Impact factor: 3.134

4.  Global rating of change scales: a review of strengths and weaknesses and considerations for design.

Authors:  Steven J Kamper; Christopher G Maher; Grant Mackay
Journal:  J Man Manip Ther       Date:  2009

5.  The Bournemouth Questionnaire as an outcome measure in the rehabilitation of a person suffering with mechanical neck and arm pain and concurrent Charcot-Marie-Tooth disease: a case report.

Authors:  Paul Rankin
Journal:  J Can Chiropr Assoc       Date:  2006-09

6.  Education, night splinting and exercise versus usual care on recovery and conversion to surgery for people awaiting carpal tunnel surgery: a protocol for a randomised controlled trial.

Authors:  Karina J Lewis; Leo Ross; Michel W Coppieters; Bill Vicenzino; Annina B Schmid
Journal:  BMJ Open       Date:  2016-09-16       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.